Telomerase inhibition and telomere erosion: a two-pronged strategy in cancer therapy

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.24, Iss.7, 2003-07, pp. : 328-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telomerase Inhibition in Cancer Therapeutics: Molecular-Based Approaches

Current Medicinal Chemistry, Vol. 13, Iss. 24, 2006-10 ,pp. : 2875-2888

Bentham Science Publishers

Access to resources Recommend Favorite

Telomerase and telomere inhibitors in

By Sharma S. Raymond E. Soda H. von Hoff D.D.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 9, 1997-09 ,pp. : 1179-1186

Informa Healthcare

Access to resources Recommend Favorite

Telomerase Inhibition and Cancer: Might Platinum Based Drugs have a Future as Anti-telomerase Pharmacological Approach?

Current Medicinal Chemistry, Vol. 12, Iss. 26, 2005-12 ,pp. : 3091-3102

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Targeting Telomere Maintenance Mechanisms in Cancer Therapy)

Current Pharmaceutical Design, Vol. 20, Iss. 41, 2014-12 ,pp. : 6359-6360

Bentham Science Publishers

Access to resources Recommend Favorite

RET inhibition: implications in cancer therapy

By Borrello Maria Grazia Ardini Elena Locati Laura D Greco Angela Licitra Lisa Pierotti Marco A

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 4, 2013-04 ,pp. : 403-419

Informa Healthcare

Access to resources Recommend Favorite